Replimune Group Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Replimune Group Inc
CIK #0001737953
EDGAR Form CIK 2011 - 2026
10-K [0001737953]
10-Q [0001737953]
3 [0001737953]
4 [0001737953]
8-K [0001737953]
SC 13D [0001737953]
SC 13G [0001737953]
Form 13D/13G Filer Form 13D/13G Subject Filed
Ridgeback Capital Investments LP Replimune Group Inc [2026-05-21]
Suvretta Capital Management LLC Replimune Group Inc [2026-05-12]
RTW Investments LP Replimune Group Inc [2025-11-14]
Point72 Asset Management LP Replimune Group Inc [2025-07-31]
Baker Bros Advisors LP Replimune Group Inc [2025-03-07]
Morgan Stanley Replimune Group Inc [2024-02-09]
State Street Corp Replimune Group Inc [2024-01-25]
Baker Bros Advisors LP Replimune Group Inc [2023-02-14]
BlackRock Inc Replimune Group Inc [2023-02-03]
Price T Rowe Associates Inc /MD/ Replimune Group Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2026
Sarchi Christopher
Replimune Group Inc
Hill Emily Luisa
Patel Sushil
Schwendenman Andrew
Astley-Sparke Philip
Xynos Konstantinos
Dhingra Kapil
Pucci Paolo
Slattery Joseph P
Peeples-Dyer Veleka
Weinand Dieter
Baker Brothers Life Sciences LP
Baker Bros Advisors GP LLC
667 LP
Baker Julian
Baker Felix
Baker Bros Advisors LP
Oliger Christy J
Balachandran Madhavan
Goller Michael
Love Colin
Coffin Robert
Levitsky Hyam
Esposito Pamela
Lewis Tanya
Franchi Jean M
Slootweg Hugo Alexander
Rhodes Jason P
Stampacchia Otello
Omega Fund IV LP
Omega Fund IV GP LP
Omega Fund IV GP Manager Ltd
Pirzkall Andrea
Paster Anne-Mari
Atlas Venture Fund X LP
Gorgol Stephen A
Kaufman Howard
Atlas Venture Opportunity Fund I LP
Atlas Venture Associates Opportunity I LLC
Atlas Venture Associates Opportunity I LP
Lim Richard J
Bain Capital Life Sciences Fund LP
Schwartz Jeffrey Lawrence
BCIP Life Sciences Associates LP
Bain Capital Life Sciences Partners LP
Koppel Adam
Bain Capital Life Sciences Investors LLC
Atlas Venture Associates X LLC
Atlas Venture Associates X LP
Forbion Capital Fund III Cooperatief UA
Redmile Group LLC
Green Jeremy
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Replimune Group Inc REPL
Common Stock
2026-02-18 Gift 25,000 $0.00
Replimune Group Inc REPL
Common Stock
2025-12-19 Grant 10,000 $0.00
Replimune Group Inc REPL
Common Stock
2025-12-19 Grant 60,000 $0.00
Replimune Group Inc REPL
Common Stock
2025-12-19 Grant 35,000 $0.00
Replimune Group Inc REPL
Common Stock
2025-12-19 Grant 200,000 $0.00
Replimune Group Inc REPL
Common Stock
2025-12-19 Grant 60,000 $0.00
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
2025-12-09 Option exercise 3,169 $0.00
Replimune Group Inc REPL
Common Stock
2025-12-09 Option exercise 3,169 $1.75 5,546
Replimune Group Inc REPL
Common Stock
2025-12-09 Sell 3,169 $10.40 32,958
Replimune Group Inc REPL
Common Stock
2025-12-02 Sell 10,000 $11.13 111,300
Replimune Group Inc REPL
Common Stock
2025-11-17 Sell 5,208 $9.10 47,393
Replimune Group Inc REPL
Common Stock
2025-11-17 Sell 7,248 $9.10 65,957
Replimune Group Inc REPL
Common Stock
2025-08-15 Sell 9,154 $5.37 49,157
Replimune Group Inc REPL
Common Stock
2025-05-20 Sell 32,279 $8.06 260,169
Replimune Group Inc REPL
Common Stock
2025-05-20 Sell 3,749 $8.05 30,179
Replimune Group Inc REPL
Common Stock
2025-05-20 Sell 2,535 $8.05 20,407
Replimune Group Inc REPL
Common Stock
2025-05-20 Sell 3,287 $8.05 26,460
Replimune Group Inc REPL
Common Stock
2025-05-20 Sell 25,105 $8.06 202,346
Replimune Group Inc REPL
Common Stock
2025-05-20 Sell 7,952 $8.06 64,093
Replimune Group Inc REPL
Stock Option (right to buy) · derivative
2025-04-01 Grant 32,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com